Clinical trial Recruiting at 5 sites Interventional Ages 16 and up Women only

Nurse Family Partnership program for first-time mothers in Norway

Official title: The Mother in Norway Study - A Randomised Trial of Nurse-Family Partnership (NFP)

Run by Oslo Metropolitan University · NCT05895604 · Data updated 2026-11-12

This study tests if the Nurse Family Partnership program can help first-time mothers in Norway reduce child abuse and improve their family's well-being compared to standard care.

Quick facts

Study typeInterventional
Ages16 Years and up
SexWomen only
Enrollment700 (estimated)
SponsorOslo Metropolitan University
Academic / other
Locations5 sites (Bergen, Bergen and 4 other locations)
StatusRecruiting
StartedJune 1, 2023
Main results expectedDecember 31, 2028
Study endsDecember 31, 2042
Registry record updatedAugust 11, 2025
Trial IDNCT05895604 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are first-time mothers who are currently pregnant and less than 28 weeks gestation.

Probably not a fit

Patients who have had previous live births or are not currently pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the Nurse Family Partnership (NFP) program in Norway, aimed at reducing child abuse and social inequality among first-time mothers. It involves a randomized controlled trial with 700 participants, where half will receive NFP services and the other half will receive standard care. The primary focus is on assessing violence towards mothers and their children through questionnaires and observation tests at various stages of the child's development. Additionally, the study will analyze health-related outcomes and conduct cost-effectiveness evaluations to improve service delivery.

Why it matters

Potential benefit: If successful, this program could significantly reduce instances of violence against mothers and their children, improving overall maternal and child health.

How similar studies have gone: Previous studies of the Nurse Family Partnership program in other regions have shown positive outcomes, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Female; No previous live births; Currently pregnant; Gestation period less than 28 weeks (i.e., less than or equal to 27 weeks, 6 days) at time of recruitment; Live within an area serviced by a NFP Implementing Agency; Not currently enrolled in the study; professionals are concerned about the pregnancy / impending parenthood

Exclusion Criteria: Women who have had a previous live birth; Women who are not currently pregnant; Women who are past their 28th week of gestation (i.e., greater than or equal to 28 weeks, 0 days) at time of recruitment; Women who live outside of an area serviced by a NFP Implementing Agency; Women who are currently enrolled in the study; professionals are not concerned about the pregnancy / impending parenthood

Where it's running

  • Region Vestland
    Bergen, Bergen, Norway
    Recruiting
  • Region Agder
    Kristiansand, Kristiansand, Norway
    Recruiting
  • Region Rogaland
    Sandnes, Sandnes, Norway
    Recruiting
  • Region Trøndelag
    Trondheim, Trondheim, Norway
    Recruiting
  • Region Oslo
    Oslo, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.